Tivic Health to Report Q1 2024 Financial Results and Subsequent Events on May 15th Via Conference Call and Webcast
Tivic Health to Report Q1 2024 Financial Results and Subsequent Events on May 15th Via Conference Call and Webcast
SAN FRANCISCO – (Business Wire) – May 13, 2024 – Tivic Health Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it will report its Q1 2024 financial results via pre-recorded conference call and webcast on Wednesday, May 15th at 1:30 PM PT / 4:30 PM ET.
舊金山 —（美國商業資訊）— 2024年5月13日 — Tivic 健康系統公司 開發和商業化生物電子醫學的健康科技公司（“Tivic Health”，納斯達克股票代碼：TIVC）今天宣佈，將於5月15日星期三通過預先錄製的電話會議和網絡直播報告其2024年第一季度的財務業績第四 太平洋時間下午 1:30 /美國東部時間下午 4:30。
Teleconference Details:
電話會議詳情：
Toll Free: 877-545-0523
International: 973-528-0016
Participant Access Code: 464810
免費電話：877-545-0523
國際：973-528-0016
參與者訪問碼：464810
Webcast Link
網絡直播鏈接
About Tivic
關於 Tivic
Tivic is a commercial health tech company advancing the field of bioelectronic medicine. Tivic's patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Tivic's non-invasive and targeted approach to the treatment of inflammatory chronic health conditions gives consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. Tivic's first commercial product ClearUP is an FDA approved, award-winning, handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and is available through online retailers and commercial distributors. For more information visit http://tivichealth.com @TivicHealth
Tivic 是一家推動生物電子醫學領域發展的商業健康科技公司。Tivic 的專利技術平台利用對三叉神經、交感神經和迷走神經結構的刺激。Tivic的非侵入性和針對性治療炎症性慢性疾病的方法爲消費者和提供者提供了高安全性、低風險和廣泛應用的無藥物治療解決方案。Tivic 的第一款商用產品 ClearUp 是一款經美國食品藥品管理局批准、屢獲殊榮的手持式生物電子鼻竇設備。ClearUp 經過臨床驗證，醫生推薦，可通過在線零售商和商業分銷商購買。欲了解更多信息，請訪問 http://tivichealth.com @TivicHealth
Forward-Looking Statements
前瞻性陳述
This press release may contain "forward-looking statements" that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as "anticipate," "believe," "contemplate," "could," "estimate," "expect," "intend," "seek," "may," "might," "plan," "potential," "predict," "project," "target," "aim," "should," "will" "would," or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems, Inc.'s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, many of which are out of Tivic's control. Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of relevant risks and uncertainties, and other important factors, any of which could cause Tivic's actual results to differ from those contained in the forward-looking statements, see Tivic's filings with the SEC, including, its Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 25, 2024, under the heading "Risk Factors"; as well as the company's subsequent filings with the SEC. Forward-looking statements contained in this press release are made as of this date, and Tivic Health Systems, Inc. undertakes no duty to update such information except as required by applicable law.
本新聞稿可能包含受重大風險和不確定性影響的 “前瞻性陳述”。本新聞稿中包含的所有陳述，除歷史事實陳述外，均爲前瞻性陳述。本新聞稿中包含的前瞻性陳述可以通過使用 “預期”、“相信”、“考慮”、“可以”、“估計”、“期望”、“打算”、“尋求”、“可能”、“可能”、“計劃”、“潛力”、“預測”、“項目”、“目標”、“目標”、“應該”、“將” 或儘管並非所有前瞻性陳述都包含這些詞語，但對這些詞語或其他類似表達方式持否定態度。前瞻性陳述基於 Tivic Health Systems, Inc.的當前預期，並受難以預測的固有不確定性、風險和假設的影響。此外，某些前瞻性陳述基於對未來事件的假設，這些假設可能並不準確。 由於各種因素，其中許多因素是Tivic無法控制的，實際結果可能與任何前瞻性陳述中包含的結果存在重大差異。因此，提醒您不要過分依賴此類前瞻性陳述。有關相關風險和不確定性以及其他重要因素的討論，其中任何一個都可能導致Tivic的實際業績與前瞻性陳述中的不同，請參閱Tivic向美國證券交易委員會提交的文件，包括其於2024年3月25日向美國證券交易委員會提交的標題爲 “風險因素” 的10-K表年度報告；以及該公司隨後向美國證券交易委員會提交的文件。本新聞稿中包含的前瞻性陳述自該日起作出，除非適用法律要求，否則Tivic Health Systems, Inc.沒有義務更新此類信息。
Investor Contact:
投資者聯繫人：
Hanover International, Inc.
漢諾威國際有限公司
譯文內容由第三人軟體翻譯。